Newsfeeds Archive - Page 3 of 4

1 minute read

News

Ironwood Presents New Data on Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old at Digestive Disease Week 2023

May 8, 7:32 AM

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), a GI-focused healthcare company, presented findings during the 2023 Digestive Disease Week® (DDW) meeting from a Phase III clinical trial on the potential of

IRWD

1 minute read

Earnings

Recap: Ironwood Pharmaceuticals Q1 Earnings

By Benzinga Insights

May 4, 7:45 AM

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM. Here’s what…

IRWD

31 minute read

Earnings

Earnings Scheduled For May 4, 2023

By Benzinga Insights

May 4, 6:34 AM

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.

AAOI

9 minute read

Earnings

Earnings Scheduled For February 16, 2023

By Benzinga Insights

February 16, 6:07 AM

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year 2022.

AEL

1 minute read

Why Ironwood Pharmaceuticals Shares Are Falling During Monday’s Session

By Henry Khederian

January 9, 3:15 PM

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) shares are trading lower by 10.00% to $11.30 Monday afternoon after the company cut its FY22 sales guidance below analyst estimates and issued FY23 sales guidance below analyst estimates.

IRWD

31 minute read

Earnings

Earnings Scheduled For November 3, 2022

By Benzinga Insights

November 3, 5:42 AM

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

AAOI

28 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

October 10, 12:29 PM

During Monday's trading, 528 companies set new 52-week lows.

$APE

23 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

October 7, 2:27 PM

On Friday, 404 stocks made new 52-week lows.

$APE

1 minute read

Ironwood Shares Positive Top-line Data From Late-Stage Functional Constipation Candidate Study In Patients Aged 6-17 Years

By Ragothaman Srinivasan

September 6, 11:09 AM

Ironwood Pharmaceuticals (NASDAQ: IRWD) announced positive top-line data from its Phase 3 clinical trial evaluating LINZESS (linaclotide) 72 mcg in pediatric patients aged 6-17 with functional constipation (FC).

IRWD

1 minute read

Ironwood’s Constipation Drug Shows Efficacy In Pediatric Patients

By Vandana Singh

September 6, 9:26 AM

Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) announced topline data from a Phase 3 trial evaluating Linzess (linaclotide) 72 mcg in pediatric patients aged 6-17 with functional constipation.

ABBV